Daud Ibrahim I, Ogolla Sidney, Amolo Asito S, Namuyenga Eunice, Simbiri Kenneth, Bukusi Elizabeth A, Ng'ang'a Zipporah W, Ploutz-Snyder Robert, Sumba Peter O, Dent Arlene, Rochford Rosemary
Center for Global Health Research, Kenya Medical Research Institute, Kisumu, Kenya.
Matern Child Health J. 2015 Mar;19(3):606-14. doi: 10.1007/s10995-014-1546-4.
The role of Plasmodium falciparum malaria in Epstein-Barr virus (EBV) transmission among infants early in life remain elusive. We hypothesized that infection with malaria during pregnancy could cause EBV reactivation leading to high EBV load in circulation, which could subsequently enhance early age of EBV infection. Pregnant women in Kisumu, where P. falciparum malaria is holoendemic, were actively followed monthly through antenatal visits (up to 4 per mother) and delivery. Using real-time quantitative (Q)-PCR, we quantified and compared EBV and P. falciparum DNA levels in the blood of pregnant women with and without P. falciparum malaria. Pregnant women that had malaria detected during pregnancy were more likely to have detectable EBV DNA than pregnant women who had no evidence of malaria infection during pregnancy (64 vs. 36 %, p = 0.01). EBV load as analyzed by quantifying area under the longitudinal observation curve (AUC) was significantly higher in pregnant women with P. falciparum malaria than in women without evidence of malaria infection (p = 0.01) regardless of gestational age of pregnancy. Increase in malaria load correlated with increase in EBV load (p < 0.0001). EBV load was higher in third trimester (p = 0.04) than first and second trimester of pregnancy independent of known infections. Significantly higher frequency and elevated EBV loads were found in pregnant women with malaria than in women without evidence of P. falciparum infection during pregnancy. The loss of control of EBV latency following P. falciparum infection during pregnancy and subsequent increase in EBV load in circulation could contribute to enhanced shedding of EBV in maternal saliva and breast milk postpartum, but further studies are needed.
恶性疟原虫疟疾在婴儿生命早期爱泼斯坦-巴尔病毒(EBV)传播中的作用仍不明确。我们推测,孕期感染疟疾可能导致EBV重新激活,从而使循环中的EBV载量升高,进而可能增加EBV感染的早期发生率。在恶性疟原虫疟疾为高度地方性流行的基苏木,对孕妇进行积极的每月一次产前检查随访(每位母亲最多4次)直至分娩。我们使用实时定量(Q)-PCR技术,对有或无恶性疟原虫疟疾的孕妇血液中的EBV和恶性疟原虫DNA水平进行了定量和比较。孕期检测到疟疾的孕妇比孕期无疟疾感染证据的孕妇更有可能检测到EBV DNA(64%对36%,p = 0.01)。通过量化纵向观察曲线下面积(AUC)分析的EBV载量,在感染恶性疟原虫疟疾的孕妇中显著高于无疟疾感染证据的孕妇(p = 0.01),且与孕周无关。疟疾载量的增加与EBV载量的增加相关(p < 0.0001)。不考虑已知感染情况,孕晚期的EBV载量高于孕早期和孕中期(p = 0.04)。孕期感染疟疾的孕妇中EBV的频率和载量显著高于孕期无恶性疟原虫感染证据的孕妇。孕期感染恶性疟原虫后EBV潜伏控制的丧失以及随后循环中EBV载量的增加,可能导致产后母体唾液和母乳中EBV脱落增加,但仍需进一步研究。